Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

NCT01627340 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

667

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

BIOLOGICAL: Engerix™-B vaccine

Sponsor

GlaxoSmithKline